Magnetic Jewelry Therapy - Bio Magnetic Therapy News

Bio Magnetic Therapy News

Mortal Kombat - Walkthrough & Moves List Thursday, July 7, 2011 @ 1:28AM* * ** *** *** ** * * * ** * * *** ** *** ** ** * * * * * * * * * * * * ** ** * * * * * * ** * * * *** * **** * *** * * * ** * *** **** * * * * * * * * * * * * * * * * * * * * * * * * ** ...
NYU Cancer Institute scientists present new research findings at ASCO 2011 Wednesday, June 8, 2011 @ 6:50AMExperts from The Cancer Institute, an NCI-designated cancer center, at NYU Langone Medical Center presented new research findings at the 47th American Society of Clinical Oncology (ASCO) 2011 Annual Meeting in Chicago, IL.
New Biomarkers Allow For Better Diagnosis, Prognosis And Response-to-Treatment Evaluation In Multiple Sclerosis And ... Tuesday, May 31, 2011 @ 8:31AMBiomarkers - surrogates which can be objectively measured and used as indicators for certain biological states, salutogenetic or pathogenetic processes or responses to pharmacological treatments - are of increasing importance in many areas of modern medicine, but especially so in neuroscience. Neurological diseases are most complex in nature, sometimes difficult to detect, and when relying only ...
EURETINA honors Retina Implant founder with Innovation Awards in the field of artificial vision Tuesday, May 31, 2011 @ 6:28AMRetina Implant AG today announced that the Company's founder Professor Eberhart Zrenner M.D. was awarded the second prize by The European Society for Retina Specialists.
Flex Fuels Energy, Inc., COAG Proof of Concept Success Thursday, April 14, 2011 @ 7:30AMLONDON--(Marketwire - 04/14/11) - Flex Fuels Energy, Inc. ("Flex" or the "Company") (OTC.BB: FXFL - News ) announces a development milestone at its 63% owned subsidiary, BioAMD Holdings Limited ("Bio-AMD"). Bio-AMD is targeting its medical diagnostic device technologies at the fast growing Point of Care market. COAG blood coagulation monitor -- Proof of Concept Success Bio-AMD is pleased to ...
Gilenya can reduce risk of disability progression in patients with RRMS Monday, April 11, 2011 @ 1:40AMA new analysis demonstrated that Gilenya reduced the risk of disability progression in patients with relapsing-remitting multiple sclerosis, regardless of treatment history. This analysis of the phase III two-year FREEDOMS study is one of 11 abstracts on Gilenya being presented at the 63rd annual meeting of the American Academy of Neurology.
Bio-resonance therapy Wednesday, March 16, 2011 @ 11:46PMLIFE is an energy phenomenon, and everything that happens in our body involves an energy exchange or movement.
Vertex announces positive interim results from telaprevir Phase 2 study in patients with HCV, HIV Thursday, March 3, 2011 @ 2:04AMVertex Pharmaceuticals Incorporated announced today interim results from an ongoing, two-part, Phase 2 study evaluating telaprevir in combination with pegylated-interferon and ribavirin compared to pegylated-interferon and ribavirin alone in people who are infected with both genotype 1 hepatitis C virus and human immunodeficiency virus, also known as HCV-HIV co-infection.
Handheld nanoLAB detects disease proteins in minutes Wednesday, February 23, 2011 @ 3:26PMIn 2009, Stanford University faculty member Shan Wang and doctoral students Richard Gaster and Drew Hall demonstrated that they could use the same ultrasensitive magnetic sensors that form the basis of today's compact, high-capacity disk drives in combination with mass-produced magnetic nanotags to detect small amounts of cancer-associated proteins (click here for earlier story).
Enabling nanoparticles to penetrate deeply in tumors Wednesday, February 23, 2011 @ 3:26PMToo often, researchers designing nanoparticles capable of delivering effective doses of anticancer agents to tumors must balance the need to choose a nanoparticle that is small enough to escape the leaky blood vessels that surround tumors but large enough to avoid rapid clearance from the blood stream via the kidneys. Balancing these two requirements usually results in using nanoparticles that ...
Tracking neural stem cells Monday, February 14, 2011 @ 8:05AM(PhysOrg.com) -- Magnetic nanoparticles could be used to track neural stem cells after a transplant in order to monitor how the cells heal spinal injuries, say UCL scientsts.
Early MRI in young adults associated with lower rate of stroke misdiagnosis Friday, February 11, 2011 @ 9:17AMWhile the American Stroke Association reports that stroke is the third leading cause of death and one of the top causes of disability in the United States, young adults showing signs of suffering a stroke are sometimes misdiagnosed in hospital emergency rooms, preventing them from receiving early effective treatment that can prevent serious damage.
Research and Markets: Encyclopedia of Biomaterials and Biomedical Engineering, Second Edition (Four-Volume Set ... Thursday, February 3, 2011 @ 12:42PMResearch and Markets has announced the addition of the "Encyclopedia of Biomaterials and Biomedical Engineering, Second Edition " book to their offering.
Reportlinker Adds Proteomics - Technologies, Markets and Companies Tuesday, December 21, 2010 @ 11:18AMReportlinker.com announces that a new market research report is available in its catalogue:
Single quantum dot nanowire photodetectors Tuesday, December 14, 2010 @ 8:43AMMoving a step closer toward quantum computing, a research team in the Netherlands recently fabricated a photodetector based on a single nanowire, in which the active element is a single quantum dot with a volume of a mere 7,000 cubic nanometers. The device is described in the American Institute of Physics' journal Applied Physics Letters.
S*BIO's Novel JAK2 Inhibitor SB1518 Is Shown to Be a Safe and Effective Therapy in Phase 1/2 Studies For Patients with ... Monday, December 6, 2010 @ 7:00AMS*BIO Pte Ltd today announced that data from Phase 1/2 studies for its novel JAK2 inhibitor SB1518 indicates clinical efficacy and good tolerability for the treatment of patients with symptomatic myelofibrosis and enlarged spleens.
Reportlinker Adds Cell Therapy - Technologies, Markets and Companies Tuesday, November 9, 2010 @ 1:43PMReportlinker.com announces that a new market research report is available in its catalogue:
Ultrasensitive biosensor can detect proteins, aid in cancer diagnosis Monday, September 20, 2010 @ 12:31PMResearchers at Boston College discovered that a cluster of carbon nanotubes coated with a thin layer of protein-recognizing polymer forms a biosensor capable of using electrochemical signals to detect minute amounts of proteins. This new biosensor could provide a crucial new diagnostic tool for the detection of cancer and other illnesses.
New approach to evaluate risk of cardiovascular disease Thursday, September 16, 2010 @ 3:29AMA new approach to evaluating a person's risk of cardiovascular disease, stroke, high blood pressure, or heart failure is reported this month in the International Journal of Data Mining, Modelling and Management. The technique uses fuzzy logic to teach a neural network computer program to analyze patient data and spot correlations that can be translated into a risk factor for an individual.
Brain Tumor Imaging And Treatment Employing Iron Oxide Nanoparticles Wednesday, August 4, 2010 @ 5:22AMTiny particles of iron oxide could become tools for simultaneous tumor imaging and treatment, because of their magnetic properties and toxic effects against brain cancer cells. In mice, researchers from Emory University School of Medicine have demonstrated how these particles can deliver antibodies to implanted brain tumors, while enhancing tumor visibility via magnetic resonance imaging (MRI ...
Sucking the Ocean Through a Straw Monday, July 12, 2010 @ 4:45PM(PhysOrg.com) -- Scientists are reporting an advance toward the next big treatment revolution in dentistry - the era in which root canal therapy brings diseased teeth back to life, rather than leaving a `non-vital` or dead tooth in the mouth. In a report in the monthly journal ACS Nano: `Nanostructured Assemblies for Dental Application,` they describe a first-of-its-kind, nano-sized dental film ...
Reportlinker Adds Cardiovascular Drug Delivery - technologies, markets and companies Monday, June 7, 2010 @ 11:44AMReportlinker.com announces that a new market research report is available in its catalogue:
Reportlinker Adds Proteomics - Technologies, Markets and Companies Thursday, June 3, 2010 @ 11:24AMReportlinker.com announces that a new market research report is available in its catalogue:
Low-cost, ultra-fast DNA sequencing brings diagnostic use closer Wednesday, May 19, 2010 @ 3:32PMSequencing DNA could get a lot faster and cheaper -- and thus closer to routine use in clinical diagnostics - thanks to a new method developed by a research team based at Boston University. The team has demonstrated the first use of solid state nanopores -- tiny holes in silicon chips that detect DNA molecules as they pass through the pore -- to read the identity of the four nucleotides that ...
Houghton College Hosts First Mini-Cyclotron Conference Monday, April 19, 2010 @ 11:00PMScience takes center stage on April 24, 2010 as Houghton College welcomes visitors from around the United States to the very first mini-cyclotron conference. The conference will be held at the college and will welcome scientists and students from Rutgers, Caltech, the University of Maryland, SLAC National Accelerator Laboratory, the National Superconducting Cyclotron Laboratory, and several ...
2010 Translational Regenerative Medicine Forum to feature Bioheart's cell therapies for congestive heart failure Wednesday, March 31, 2010 @ 5:20AMBioheart, Inc., announced today that Dr. Karl E. Groth, the Company's Chairman and CEO will speak at the 2010 Translational Regenerative Medicine Forum in Winston-Salem, North Carolina, on April 8. Dr. Groth will discuss Bioheart's cell therapies for Congestive Heart Failure.
Tiny gold probes give scientists a sense of how disease develops Sunday, March 28, 2010 @ 6:08PMTiny chemical sensors implanted into patients could help diagnose disease and track its progress, following a development by scientists.
Like little golden assassins, 'smart' nanoparticles identify, target and kill cancer cells Monday, March 8, 2010 @ 4:25PMAnother weapon in the arsenal against cancer: Nanoparticles that identify, target and kill specific cancer cells while leaving healthy cells alone.
Flex Fuels Energy, Inc. Makes Investment in Bio-AMD, a Medical Device Company Thursday, March 4, 2010 @ 7:23AMLONDON -- Flex Fuels Energy, Inc. announces that on February 25, 2010 it entered into a Subscription and Shareholders Agreement with Bio AMD Holdings Limited, a UK limited company .
Rexahn Pharmaceuticals Provides Key Goals for 2010 Wednesday, February 17, 2010 @ 7:00AMROCKVILLE, Md.----Rexahn Pharmaceuticals, Inc. , a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today provided guidance on its key pipeline, scientific and business goals for 2010.
'Nanobubbles' kill cancer cells Thursday, February 4, 2010 @ 2:43PM(PhysOrg.com) -- Using lasers and nanoparticles, scientists at Rice University have discovered a new technique for singling out individual diseased cells and destroying them with tiny explosions. The scientists used lasers to make "nanobubbles" by zapping gold nanoparticles inside cells. In tests on cancer cells, they found they could tune the lasers to create either small, bright bubbles that ...
Engineers develop cancer-targeting nanoprobe sensors Monday, February 1, 2010 @ 3:12PM(PhysOrg.com) -- Scientists at UC Berkeley have created smart nanoprobes that may one day be used in the battle against cancer to selectively seek out and destroy tumor cells, as well as report back on the mission's status. The research team created multi-functioning probes, which they have dubbed nanocorals.
Growing cartilage -- no easy task Monday, February 1, 2010 @ 2:57PMNorthwestern University researchers are the first to design a bioactive nanomaterial that promotes the growth of new cartilage in vivo and without the use of expensive growth factors. Minimally invasive, the therapy activates the bone marrow stem cells and produces natural cartilage. No conventional therapy can do this.
Healthbeat Segment: Shaking Up Cancer Thursday, January 28, 2010 @ 10:11PMScientists have discovered a new approach to fighting cancers that cannot be destroyed by radiation or chemotherapy.
MBL generates human monoclonal antibodies against pandemic A type influenza virus Wednesday, January 27, 2010 @ 4:08AMMedical & Biological Laboratories Co., Ltd. (MBL), with the collaboration of Osaka University, has successfully generated several fully human monoclonal antibodies against pandemic A (H1N1 and H3N2) type influenza virus by utilizing blood samples from volunteers who were inoculated with influenza vaccine.
Olfactory dysfunction may serve as an early diagnostic tool for Alzheimer's disease Wednesday, January 13, 2010 @ 2:20AMA study published in the January 13, 2010 issue of the Journal of Neuroscience links a loss of smell function in Alzheimer's disease (AD) model animals with amyloid β (protein) accumulation in the brain, a distinguishing hallmark of Alzheimer's disease. Research conducted by NYU Langone Medical Center suggests that olfactory dysfunction, a common symptom of AD, may serve as an early diagnostic ...
Reportlinker Adds Nanotechnology in Medical Applications: The Global Market Monday, January 4, 2010 @ 8:15AMReportlinker.com announces that a new market research report is available in its catalogue:
DGAP-News: Nanostart majority-owned MagForce Nanotechnologies AG names Dr. Peter Heinrich as new CEO Thursday, December 10, 2009 @ 12:54AMDissemination of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer / publisher is solely responsible for the content of this announcement.
New imaging nano-technique to change the way we see disease Tuesday, December 8, 2009 @ 4:32AM(PhysOrg.com) -- New nano-technology being developed by physicists at Macquarie University could help medical professionals better understand and more effectively treat cancer and other diseases.
Microscopy reveals structure of calcite shells Monday, November 30, 2009 @ 4:20PM(PhysOrg.com) -- Lara Estroff and colleagues have taken a deep, detailed look at the way lab-created calcite crystals, similar to those found in nature, grow in tandem with proteins and other large molecules.
FDA approves sNDA for pediatric autism drug ABILIFY Friday, November 20, 2009 @ 10:49PMBristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self ...
Highlight: STM banopatterning on pristine Nb-doped SrTiO3 surfaces Wednesday, November 4, 2009 @ 3:37PMCollaborative users from the Advanced Photon Source at the Argonne National Laboratory, working with the Electronic & Magnetic Materials & Devices Group, have found a controllable way to modify the surfaces of pristine Nb-doped SrTiO3 (Nb:STO) at the nanoscale.
Prostate Cancer Screening: New Technology 300 Times More Sensitive Than Commercial Tests, Defines New PSA 'Zero' Tuesday, October 20, 2009 @ 10:23AMA team of Northwestern University researchers, using an extremely sensitive tool based on nanotechnology, has detected previously undetectable levels of prostate-specific antigen (PSA) in patients who have undergone radical prostatectomy.
In Brief: Exploring the limits of antiferromagnetism in nanostructured materials Friday, October 9, 2009 @ 12:38PM(PhysOrg.com) -- Researchers in the Electronic & Magnetic Materials & Devices Group (Argonne National Laboratory) and at Politecnico di Milano in Italy explored the limits of antiferromagnetism in a nanostructured material for the first time, measuring the temperature required to support antiferromagnetic order in atomic monolayers of manganese on tungsten as the dimensions of the structures are ...
The ThermoDox and MR-HIFU program shows great promise for treating life-threatening cancers Wednesday, September 23, 2009 @ 8:25AMRoyal Philips Electronics (NYSE: PHG; AEX: PHI) and Celsion Corporation (NASDAQ: CLSN) today announced that their joint research program to evaluate ThermoDox® in combination with MR-HIFU (Magnetic Resonance guided High Intensity Focused Ultrasound) as a combination therapy to non-invasively treat difficult cancers has successfully completed the feasibility stage.
Reportlinker Adds Biomarkers- Advanced Technologies and Global Market (2009-2014) Thursday, September 10, 2009 @ 9:41AMNEW YORK----Reportlinker.com announces that a new market research report is available in its catalogue.
Researchers Use Golden Nanotubes For Imaging Agent To Detect Tumor Cells, Map Sentinel Lymph Node Monday, August 31, 2009 @ 12:13AMBiomedical researchers at the University of Arkansas for Medical Sciences in Little Rock have developed a special contrast-imaging agent that is capable of molecular mapping of lymphatic endothelial cells and detecting cancer metastasis in sentinel lymph nodes.
New stem cell research unlocks unknown therapies Thursday, May 21, 2009 @ 12:22PMNew treatments for the devastating Parkinson's disease and ALS are in clinical studies in Sweden, thanks to breaking new stem cell research. This news was presented today by Dr. Jonas Frisen, Professor of stem cell research at Karolinska Institutet, at the world's largest biotech convention, BIO 2009 in Atlanta.
Microorganisms for imaging and/or treatment of tumors Tuesday, May 12, 2009 @ 4:51PMModified viruses encoding transporter proteins and methods for preparing the modified viruses are provided. Vaccines that contain the viruses are provided. The viruses also can be used in diagnostic methods, such detection and imaging
Nanotechnology holds promise for STD drug delivery Sunday, May 3, 2009 @ 4:41PMYale researchers describe a breakthrough in safe and effective administration of potential antiviral drugs - small interfering RNA (siRNA) molecules that silence genes - the first step in development of a new kind of treatment for sexually transmitted diseases (STDs). The work is reported May 4 as an advance online publication of Nature Materials.